Is expensive medicine part of US life?
Five Killer Charts
Good morning – here are your five chart for the day. Each one comes snap stat, quick take and why it matters. Skim, steal, forward (but always credit!!).
CHART 1 • US drug prices dwarf global competition
American patients face prescription costs nearly three times higher than wealthy peers, with pharma companies setting prices with abandon in an unregulated market. Trump's "most favoured nation" executive order signed in May demands US drug prices match the lowest prices paid by other developed nations. The policy could slash American drug costs by 59-90% but threatens the $722.5 billion pharma industry built on US premium pricing.
Snap stat – US drug prices are 3x higher than average across 33 wealthy countries.
Quick take – Trump's executive order forces alignment with lowest global prices threatening industry profits.
Why it matters – Americans subsidise global drug development through triple pricing while other nations get discounts.
Steal-this-caption – "Americans pay 3x more for drugs – Trump's order ends global pharma freeloading." #FiveChartsDaily
Source: Bloomberg
Want the other four? Become a paid subscriber.
